Clinical Trial Update: Tirzepatide for Obesity and Meth Use Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update notes that tirzepatide is being studied for obesity and methamphetamine use disorder, with the study currently active but not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methamphetamine Use Disorder
• Obesity

Drugs mentioned

• ZEPBOUND (tirzepatide)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Obesity, Methamphetamine Use Disorder | Phase 2 | Status: ACTIVE_NOT_RECRUITING